Bio-Techne refers to its previously announced pending acquisition by Merck KGaA, Darmstadt, Germany. The dividend is payable November 23, 2026, only if the transaction has not closed by close of business on November 13, 2026. The release does not provide transaction value or further details on the acquisition.
Key facts
BIO-TECHNE Corp has a pending acquisition by Merck KGaA, Darmstadt, Germany. source
Completion of BIO-TECHNE Corp’s pending transaction with Merck KGaA is subject to required shareholder and regulatory approvals. source